Product Description
Pharmaceutical
Raw Materials and Intermediates
AI Product Description
*The following content is generated by AI and is for reference only.
(S)-2-((Methoxycarbonyl)amino)-3-methylbutanoic acid, chemically known as N-Cbz-L-valine methyl ester or more accurately in this specific context as the methyl ester of N-methoxycarbonyl-L-valine, is a specialized chiral building block widely utilized in organic synthesis and pharmaceutical research. Its molecular formula is C7H13NO4, and it carries the CAS registry number 100856-48-4. This compound represents a protected derivative of the essential amino acid L-valine, featuring a methoxycarbonyl group attached to the nitrogen atom and a methyl ester functionality on the carboxylic acid side. The presence of these protecting groups renders the molecule stable under various reaction conditions while allowing for selective deprotection later in synthetic sequences.
The primary application of (S)-2-((Methoxycarbonyl)amino)-3-methylbutanoic acid lies in the solid-phase peptide synthesis (SPPS) and the development of complex peptidomimetics. As a chiral precursor, it serves as a critical source of the valine residue, ensuring stereochemical integrity during the assembly of bioactive peptides. Researchers frequently employ this reagent to construct drugs targeting proteases, oncology therapeutics, and antimicrobial agents where the specific configuration of the amino acid backbone is paramount for biological activity. The methoxycarbonyl moiety acts as an efficient protecting group that prevents unwanted side reactions at the amine site, facilitating high-yield coupling reactions with other amino acids or functionalized scaffolds. Furthermore, its solubility characteristics make it suitable for use in diverse solvent systems ranging from polar aprotic solvents to standard organic media used in medicinal chemistry laboratories.
In industrial settings, this compound is often sourced by fine chemical manufacturers specializing in high-purity intermediates for the drug discovery pipeline. Quality control involves rigorous analysis via HPLC and NMR spectroscopy to confirm enantiomeric excess and purity levels, typically exceeding 98%. As the pharmaceutical industry continues to advance towards personalized medicine and targeted therapies, the demand for such precisely defined chiral building blocks remains robust. Ultimately, (S)-2-((Methoxycarbonyl)amino)-3-methylbutanoic acid stands as a fundamental tool enabling the precise construction of next-generation therapeutic molecules, bridging the gap between simple amino acids and complex, life-saving medicines.